CN102225152A - Preparation method of Maiwei rehmannia oral preparation - Google Patents
Preparation method of Maiwei rehmannia oral preparation Download PDFInfo
- Publication number
- CN102225152A CN102225152A CN 201110171874 CN201110171874A CN102225152A CN 102225152 A CN102225152 A CN 102225152A CN 201110171874 CN201110171874 CN 201110171874 CN 201110171874 A CN201110171874 A CN 201110171874A CN 102225152 A CN102225152 A CN 102225152A
- Authority
- CN
- China
- Prior art keywords
- preparation
- hour
- thick paste
- fine powder
- condensed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method of a Maiwei rehmannia oral preparation, which comprises the following components: dwarf lilyturf tuber, prepared schisandra chinensis, prepared schisandra chinensis, prepared cornus, peony bark, Chinese yam, tuckahoe, rhizoma alismatis and auxiliary materials. In the preparation method disclosed by the invention, the process of the preparation is optimized according to the properties of each medicine in the Maiwei rehmannia preparation and the actions of the medicine in the formula; and compared with the prior art, the product which is prepared by the process of the invention has the advantages of high effective component content and good clinical treatment effects.
Description
Technical field: the present invention relates to a kind of preparation method of MAIWEI DIHUANG KOUFU ZHIJI, belong to the field of medicine technology.
Technical background: deficiency of YIN of both the lung and kidney, hectic fever night sweat, the dry pharynx hemoptysis, vertigo and tinnitus, soreness of the waist and knees, quenching one's thirst is clinical common sympton, the means that the traditional Chinese medical science often adopts nourishing kidney to support lung are treated it.Maiwei-dihuang preparation adds foster Radix Ophiopogonis of having both clearly, mends the Fructus Schisandrae Chinensis composition of holding back with tool with the kidney invigorating classics recipe Radix Rehmanniae Preparata, Rhizoma Dioscoreae, Fructus Corni, Rhizoma Alismatis, Cortex Moutan, Poria.In the side with Radix Rehmanniae Preparata, Radix Ophiopogonis, Rhizoma Dioscoreae, Fructus Corni and the kidney invigorating, lung, spleen, stomach earlier, the day after tomorrow cloudy Tianjin be agent structure; Can ooze again Rhizoma Alismatis, Cortex Moutan, Poria, Radix Ophiopogonis to let out and stay turbid, deficiency-heat due to the deficiency of YIN, with the Fructus Schisandrae Chinensis tonifying YIN of astringing the lung, strengthen the strong effect of yin nourishing benefit again, alleviates dry yearningly, the dry cough disease.All medicines are assisted each other, rule together up and down, and based on the tonifying the lung kidney, and full side benefit is not stayed turbid.Both be good at removing soreness of the waist and knees due to the deficiency of YIN, vertigo and tinnitus, insomnia forgetfulness, dryness of the intestine constipation, dry pharynx, symptom such as thirsty, and be good at treating the deficiency of YIN again and stay diseases such as hectic fever night sweat, nocturia, dry cough, hemoptysis spitting of blood buccal void due to turbid and the deficiency-heat is red, the few tongue of red tongue.Modern pharmacological research proves that Maiwei-dihuang preparation has blood sugar lowering, blood fat reducing, raising immunity, the anti-ageing effect of waiting for a long time.For diseases such as treatment diabetes, hyperthyroidism, pulmonary tuberculosis, chronic bronchitis, emphysema definite curative effect is arranged.Existing method of producing Maiwei-dihuang preparation generally is to adopt the method for putting down in writing on ministry standard and the Chinese Pharmacopoeia, the method of above-mentioned standard record is fairly simple, cause containing a large amount of invalid components and impurity in the product, make that the clinical efficacy of Maiwei-dihuang preparation is not ideal enough.
Summary of the invention: technical problem to be solved by this invention is to provide a kind of preparation method of MAIWEI DIHUANG KOUFU ZHIJI.
For solving the problems of the technologies described above, the present invention realizes by the following technical solutions: a kind of MAIWEI DIHUANG KOUFU ZHIJI, calculate according to composition by weight, it by Radix Ophiopogonis 30-120, Fructus Schisandrae Chinensis (system) 20-80, Radix Rehmanniae Preparata 80-320, Fructus Corni (system) 40-160, Cortex Moutan 30-120, Rhizoma Dioscoreae 40-160, Poria 30-120, Rhizoma Alismatis 30-120 and adjuvant be prepared from.
Specifically: calculate according to composition by weight, it is prepared from by Radix Ophiopogonis 60, Fructus Schisandrae Chinensis (system) 40, Radix Rehmanniae Preparata 160, Fructus Corni (system) 80, Cortex Moutan 60, Rhizoma Dioscoreae 80, Poria 60, Rhizoma Alismatis 60 and adjuvant.
The preparation method of MAIWEI DIHUANG KOUFU ZHIJI of the present invention is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, dry below 60 ℃ and 60 ℃, pulverize, add conventional adjuvant again and can make different oral formulations according to conventional method.
Specifically, the preparation method of MAIWEI DIHUANG KOUFU ZHIJI of the present invention is: Radix Ophiopogonis powder is broken into 80 purpose fine powders, the Cortex Moutan pulverize at low temperature becomes 80 purpose fine powders; Fructus Corni, Fructus Schisandrae Chinensis, Rhizoma Alismatis add 8 times of amount 65% ethanol for the first time with 65% ethanol extraction 2 times, add 6 times of amount 65% ethanol for the second time, each 2 hours, filter merge extractive liquid,, reclaim ethanol, being condensed into when relative density is 80 ℃ is 1.10～1.15 thick pastes; Radix Rehmanniae Preparata with boiling water lixiviate 5 hours, decocts with water three times with Rhizoma Dioscoreae, Poria earlier again, and each 1 hour, add 10 times of water gagings for the first time, second and third time adds 8 times of water gagings, and collecting decoction filters, and it is 1.10～1.15 thick pastes that filtrate is condensed into when relative density is 80 ℃; Above-mentioned fine powder and thick paste mixing, 60 ℃ of dryings are pulverized, and add conventional adjuvant again and can make different oral formulations according to conventional method.
Described oral formulations is meant capsule, tablet and pill.
Described tablet is meant coated tablet and Film coated tablets.
Specifically: the preparation method of capsule of the present invention is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, dry below 60 ℃ and 60 ℃, pulverize, add 0.5% magnesium stearate, mixing incapsulates, promptly.
The preparation method of pill of the present invention is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, pill, dry below 60 ℃ and 60 ℃, polishing or sugar coating or bag film-coat promptly get pill.
The preparation method of tablet of the present invention is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing are made granule, and be dry below 60 ℃ and 60 ℃, adds dried grain amount 0.5-1% magnesium stearate again, mixing, and tabletting, sugar coating or film-coat promptly get tablet.
In the prescription of Maiwei-dihuang preparation, Cortex Moutan has the effect of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, and its main effective ingredient is a paeonol, and paeonol has pharmacological actions such as antiinflammatory, antibacterial, spasmolytic, analgesia, antiallergic and immunomodulating; Because the Cortex Moutan quality is hard, in conventional crushing process, material is at the pulverizer intracavity, be subjected between steel-tooth splitting, tear the effect with grinding machinery power, make the bulky grain of medicine become granule, surface area increases, mechanical energy changes in the surface energy process, and the pulverizer temperature can raise, the corresponding rising of temperature of the Paeonia suffruticosa corium farinosum after the pulverizing, and crushing quantity is big more, and temperature is high more.And the paeonol instability, the high volatilization easily of temperature causes the content of paeonol to reduce, and finds after the experimentation, is pulverizing Cortex Moutan below 60 ℃ and 60 ℃, can effectively guarantee the content of paeonol.The Radix Rehmanniae Preparata nourishing kidney yin, life essence-filling, marrow-benefitting, warm in nature and mend, cloudy to lose the person suitable, and can solely go into kidney man.Show after deliberation, in the Radix Rehmanniae Preparata water extract, mainly contain effective ingredient such as prepared rehmannia root polysaccharide, the Radix Rehmanniae Preparata water extract has antioxidation, enriches blood, improves effects such as immunity.Radix Rehmanniae Preparata generally is directly to use water extraction in the prior art, but the inventor is through experimental studies have found that, Radix Rehmanniae Preparata soaks earlier before decocting, can improve the yield of Radix Rehmanniae Preparata water extract.The effect that Rhizoma Dioscoreae has spleen invigorating, dehumidifying, QI invigorating, lung benefiting, reinforces the kidney, benefit is smart, its effective ingredient Chinese yam polysaccharide has effects such as enhance immunity, defying age, antioxidation; Poria has eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, the effect of mind tranquilizing and the heart calming, effect such as the main effective ingredient pachyman in the Poria has enhancing immunity, protects the liver, antiviral.Studies show that, Rhizoma Dioscoreae and Poria water boiling and extraction, with direct comminution ratio, can remove a large amount of impurity, keep simultaneously Chinese yam polysaccharide and pachyman to greatest extent.Fructus Corni has the function of arresting seminal emission, arresting sweating, invigorating the liver and kidney, and its main effective ingredient is compositions such as iridoid glycosides, polysaccharide, organic acid, tannin.Studies show that in a large number Fructus Corni total glycosides has significant rabbit epidemic disease and regulates active and effects such as antiinflammatory, anticancer, blood sugar lowering, heart tonifying, loganin is a content higher effective composition in the Fructus Corni total glycosides.In the technology of existing Maiwei-dihuang preparation, Fructus Corni adopts water boiling and extraction more, finds that after deliberation Fructus Corni is made extraction solvent with ethanol, can improve the active constituent content of Fructus Corni.Fructus Schisandrae Chinensis has astringes the lung, and nourishing kidney is promoted the production of body fluid, and receives the effect of antiperspirant and arresting seminal emission.Contained schisandrin, schisandrin B are the main effectively active component of Fructus Schisandrae Chinensis retardance hepatocyte injury in the Fructus Schisandrae Chinensis.Studies show that the Fructus Schisandrae Chinensis ethanol extraction compares with the water boiling and extraction method, the content of schisandrin B is higher.Rhizoma Alismatis has diuretic, eliminating dampness by diuresis, the effect that expels the heat-evil.The effective constituent that mainly contains that contained 23-alisol acetyl B is the Rhizoma Alismatis hepatoprotective effect in the Rhizoma Alismatis can be protected the mouse liver because of carbon tetrachloride poisoning.Studies show that Rhizoma Alismatis is used ethanol extraction, avoided conventional water boiling and extraction, the shortcoming that above effective component extraction rate is low.
Compared with prior art, the present invention adopts the pulverize at low temperature Cortex Moutan, can guarantee the content of paeonol; Before the Radix Rehmanniae Preparata decocting, soak earlier, can improve the yield of Radix Rehmanniae Preparata water extract; The water decocting method extracts Rhizoma Dioscoreae and Poria, with direct comminution ratio, can remove a large amount of impurity, keep the content of its effective ingredient Chinese yam polysaccharide and pachyman simultaneously to greatest extent; Fructus Corni is made extraction solvent with ethanol, can improve content of effective such as loganin; The Fructus Schisandrae Chinensis ethanol extraction compares with the water boiling and extraction method, and the content of schisandrin B is higher; Rhizoma Alismatis is used ethanol extraction, when having avoided conventional water boiling and extraction, and the low shortcomings of effective component extraction rate such as 23-alisol acetyl B; Total glycosides in the Fructus Corni is insoluble in water, is soluble in alcohol, adopts ethanol extraction, can improve the extraction ratio of total glycosides, and the present invention detects index.The present invention is according to the character of each medicine in the Maiwei-dihuang preparation, and this medicine role in prescription, technology to Maiwei-dihuang preparation is optimized, make the refine more of this medicine, drug effect is more remarkable, for deficiency of YIN of both the lung and kidney, hectic fever night sweat, the dry pharynx hemoptysis, vertigo and tinnitus, soreness of the waist and knees etc. have better therapeutical effect.Compare with existing preparation, preparation active constituent content height of the present invention, clinical efficacy is good, has reached the purpose of invention.
The applicant has carried out following experiment, and provable the present invention has effective effect;
Experimental example 1: Cortex Moutan breaking method experimentation
Cortex Moutan has the merit of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling for Maiwei-dihuang capsule prescription Chinese crude drug.The main effective ingredient of Cortex Moutan is a paeonol, has pharmacological actions such as antiinflammatory, antibacterial, spasmolytic, analgesia, antiallergic and immunomodulating.According to production technology, need Cortex Moutan is pulverized, the general dry pulverization process that adopts, the applicant gets with a collection of Cortex Moutan medical material by discovering, changes breaking method, adopt pulverize at low temperature (material mix again pulverize) with liquid nitrogen, can reduce the loss of effective ingredient paeonol content, can guarantee effective component content, result of the test is as follows:
1, crude drug (numbering: W-1)
2, dry pulverization process (numbering: W-2): get the 100kg Cortex Moutan, be ground into 80 order fine powders.
3, pulverize at low temperature (numbering: W-3): get the 100kg Cortex Moutan, be ground into 80 order fine powders.
With paeonol content result in batch different grinding mode Cortex Moutans relatively
The result shows: pulverizing below 60 ℃ and 60 ℃, can guarantee the content of paeonol.
Experimental example 2: Fructus Schisandrae Chinensis, Fructus Corni and Rhizoma Alismatis Study on extraction
Preparation process of the present invention: get Fructus Schisandrae Chinensis (system), Fructus Corni (system) and Rhizoma Alismatis with 65% ethanol extraction 2 times, add for the first time 8 times of amount 65% ethanol (V/V), add for the second time 6 times of amount 65% ethanol (V/V), each 2 hours, filter, merge extractive liquid, reclaims ethanol, and being condensed into relative density is 1.10～1.15 (80 ℃) thick paste;
Former preparation process: get Fructus Schisandrae Chinensis (system), Fructus Corni (system) and Rhizoma Alismatis and decoct with water three times, each 1 hour, add 10 times of water gagings for the first time, second and third time adds 8 times of water gagings, collecting decoction filters, and it is 1.10～1.15 (80 ℃) thick paste that filtrate is condensed into relative density.
Detect the wherein content of schisandrin B, loganin, 23-alisol acetyl B respectively, the result is:
| Project | Preparation process of the present invention | Former preparation process |
| Schisandrin B | 0.30％ | 0.13％ |
| Loganin | 0.79％ | 0.48％ |
| 23-alisol acetyl B | 0.56％ | 0.25％ |
Above experimental result shows that the content of schisandrin B, loganin, 23-alisol acetyl B is higher in the preparation process extract of the present invention, is better than former preparation process.
Experimental example 3: Radix Rehmanniae Preparata Study on extraction
Preparation process of the present invention: Radix Rehmanniae Preparata with boiling water lixiviate 5 hours, decocts with water three times earlier, and each 1 hour, add 10 times of water gagings for the first time, second and third time adds 8 times of water gagings, and collecting decoction filters, and it is 1.10～1.15 (80 ℃) thick paste that filtrate is condensed into relative density.
Former preparation process: Radix Rehmanniae Preparata decocts with water three times, and each 1 hour, add 10 times of water gagings for the first time, second and third time adds 8 times of water gagings, and collecting decoction filters, and it is 1.10～1.15 (80 ℃) thick paste that filtrate is condensed into relative density.
Measure the yield of Radix Rehmanniae Preparata water extract respectively, the result is:
| Project | Preparation process yield of the present invention (%) | Former preparation process yield (%) |
| The Radix Rehmanniae Preparata water extract | 72％ | 61％ |
Above experimental result shows that preparation process extraction ratio of the present invention is higher, is better than former preparation process.
Experimental example 6: pharmacodynamic study
The applicant has carried out main pharmacodynamics research, data declaration beneficial effect of the present invention by experiment to the present invention.
1, extracorporeal bacteria inhibitor test
1.1 test strain
Staphylococcus aureus, Staphylococcus albus, Pseudomonas aeruginosa, escherichia coli, Bacillus proteus, alpha streptococcus, group B streptococcus are all purchased in Nat'l Pharmaceutical ﹠ Biological Products Control Institute.
1.2 sample preparation
Former technology extract: the technology according to the 5th (WS3-B-0938-91) record of the Sanitation Ministry medicine standard Chinese traditional patent formulation preparation is made extract, makes the medicinal liquid of 10% concentration (g/ml) with purified water;
Extract of the present invention: make extract according to the method for the invention, make the medicinal liquid of 10% concentration (g/ml) with purified water;
1.3 medium preparation
1.3.1 ordinary culture medium preparation
Learn from else's experience Nutrient agar behind the autoclaving, every respectively plate 10ml is poured into flat board, after solidifying promptly.
1.3.2 blood plate medium preparation
Nutrient agar behind autoclaving when being cooled to 56 ℃ of alpha streptococcuss, group B streptococcus, adds 10% aseptic degreasing fiber Sanguis caprae seu ovis, mixing, every respectively plate 10ml is poured into flat board, after solidifying promptly.
1.4 bacteriostatic test
Respectively with asepsis ring depletion Staphylococcus aureus, Staphylococcus albus, Pseudomonas aeruginosa, escherichia coli, Bacillus proteus respectively densification be inoculated into common Nutrient medium surface.Respectively with asepsis ring get alpha streptococcus, group B streptococcus respectively densification be inoculated into the blood plate media surface.Punch on flat board, the aperture is 5mm.Respectively medicinal liquid is filled it up with in each dull and stereotyped hole, cultivated after 24 hours for 37 ℃, observed result is measured antibacterial circle diameter, gets 6 result of the test averages as antibacterial circle diameter.
1.5 result
Two kinds of extracts all have bacteriostasis (seeing Table 1) to staphylococcus aureus, Staphylococcus albus, Pseudomonas aeruginosa, escherichia coli, Bacillus proteus, alpha streptococcus, group B streptococcus, see following table for details.
Table 1 bacteriostatic test result (x ± SD)
Annotate: technology of the present invention and former technology is * P＜0.05 relatively
1.6 conclusion
Above experimental studies results shows that preparation of the present invention all has bacteriostasis to staphylococcus aureus, Staphylococcus albus, Pseudomonas aeruginosa, escherichia coli, Bacillus proteus, alpha streptococcus, group B streptococcus, and fungistatic effect is better than former technology.
2, analgesic test
2.1 experimental technique
Get 48 of healthy Kunming mouses, male and female half and half, be divided into 4 groups at random, be normal saline group, preparation group of the present invention (making extract), former technology preparation group (technology according to the record of ministry standard MAIWEIDIHUANGPIAN is made extract) and aspirin group according to the method for the invention, 12 every group.Successive administration 4 days, every day 1 time, the normal saline group gives equal-volume normal saline (20ml/kg), all the other the group respectively by 1.28g/Kg (20ml/kg) dosage gavage preparation of the present invention, former technology preparation and aspirin medicinal liquid (0.25g/kg, 20ml/kg), all in last 30min behind medicine, each mouse peritoneal is only injected 0.8% acetum 0.2ml/, the number of times that writhing response appears in interior every the mice of observed and recorded 15min calculates mean and standard deviation, the comparable group differences.
2.2 result
Each administration group all can be resisted the pain reaction due to the acetic acid stimulation, makes the mouse writhing number of times obviously reduce (seeing Table 2).
The influence of table 2 pair mouse writhing number of times (n=12, x ± s)
Annotate: preparation group of the present invention and former technology preparation group be * P＜0.05 relatively
2.3 conclusion
Above experimental studies results shows that preparation group of the present invention and former technology preparation group all can be resisted the pain reaction due to the acetic acid stimulation; Preparation group wherein of the present invention is better than former technology preparation group (P＜0.05).
3, to deficiency of YIN effect of immunologic function
3.1 hemolytic plaque test: 48 of male mices, body weight 18～22g, divide 4 groups at random, be matched group, model group, preparation group of the present invention (making extract), former technology preparation group (technology according to the record of ministry standard MAIWEIDIHUANGPIAN is made extract) according to the method for the invention, 12 every group.Use T
3Method is set up the yin deficiency syndrome animal model.Gavaged distilled water or medicine every day 1 time continuous 10 days, and, gavaged T in administration beginning in the 6th day
318 μ l/ moulding in only continuous 5 days.In administration in the time of the 6th day, with fresh sheep red blood cell (SRBC) suspension (SR-BC) immunity, every Mus 4 * 10
8RBC/0.5ml ip.After immunity, put to death animal on the 4th day, separation of serum and preparation splenocyte suspension, the plaque number with on every slide of agarose slide method counting calculates cell volume.According to splenocyte concentration correction in cell volume and the mixed liquor per 1,000,000 (1 * 10
6) to contain plaque forming cells's number in the splenocyte (be PFC number/10
6Splenocyte), the blood sample specimen is pressed literature method and is detected the serum agglutinin, and the result represents with the log2 titre; Other has experiment to get 60 of mices, and body weight 17～22g with method grouping perfusion, uses T
3Method moulding and with fresh SRBC immunity, experiment finishes to put to death animal, takes blood preparation, and the reference literature method is done the E bow structure and is formed experiment, observation E bow structure formation rate, promptly the erythrocyte Flos Rosae Rugosae forms cell (ERFC) formation rate, the results are shown in following table.
The influence of deficiency of YIN mouse antibodies formation cell (x ± SD)
Annotate: preparation group of the present invention and former technology preparation group be * P＜0.05 relatively
3.2 the result shows: preparation group of the present invention and former technology preparation group all can make deficiency of YIN mice plaque forming cells number obviously raise; Make deficiency of YIN mice serum agglutinin return to normal level, increase deficiency of YIN mice E bow structure formation rate.Compare preparation group better effects if of the present invention (P＜0.05) with former technology preparation group.
The specific embodiment:
Embodiment 1:
Prescription: Radix Ophiopogonis 60g, Fructus Schisandrae Chinensis (system) 40g, Radix Rehmanniae Preparata 160g, Fructus Corni (system) 80g, Cortex Moutan 60g, Rhizoma Dioscoreae 80g, Poria 60g, Rhizoma Alismatis 60g
Technology: Radix Ophiopogonis powder is broken into 80 purpose fine powders, the Cortex Moutan pulverize at low temperature becomes 80 purpose fine powders; Fructus Corni, Fructus Schisandrae Chinensis, Rhizoma Alismatis add 8 times of amount 65% ethanol for the first time with 65% ethanol extraction 2 times, add 6 times of amount 65% ethanol for the second time, each 2 hours, filter merge extractive liquid,, reclaim ethanol, being condensed into when relative density is 80 ℃ is 1.10～1.15 thick pastes; Radix Rehmanniae Preparata with boiling water lixiviate 5 hours, decocts with water three times with Rhizoma Dioscoreae, Poria earlier again, and each 1 hour, add 10 times of water gagings for the first time, second and third time adds 8 times of water gagings, and collecting decoction filters, and it is 1.10～1.15 thick pastes that filtrate is condensed into when relative density is 80 ℃; Above-mentioned fine powder and thick paste mixing, 60 ℃ of dryings are pulverized, and add 0.5% magnesium stearate, and mixing incapsulates, and promptly gets capsule.
Usage and consumption: oral.A 3-4 grain, 3 times on the one.
Embodiment 2:
Prescription: Radix Ophiopogonis 120g, Fructus Schisandrae (processed) 80g, Radix Rehmanniae Preparata 320g, Fructus Corni (processed) 160g, Cortex Moutan 120g, Rhizoma Dioscoreae 160g, Poria 120g, Rhizoma Alismatis 120g
Technology: Radix Ophiopogonis powder is broken into 100 purpose fine powders, the Cortex Moutan pulverize at low temperature becomes 100 purpose fine powders; The ethanol extraction of Fructus Corni, Fructus Schisandrae Chinensis and 10 times of amounts 85% of Rhizoma Alismatis adding 5 hours, extracting solution filters, and reclaims ethanol and also is condensed into the thick paste that relative density is 1.10～1.15 (80 ℃); Radix Rehmanniae Preparata adds 10 times of water gagings with Rhizoma Dioscoreae, Poria again and decocted 3 hours earlier with boiling water lixiviate 8 hours, and decocting liquid filters, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, pill, 50 ℃ of dryings, polishing promptly gets pill.
Usage and consumption: oral.A 3-4 grain, 3 times on the one.
Embodiment 3:
Prescription: Radix Ophiopogonis 30g, Fructus Schisandrae (processed) 20g, Radix Rehmanniae Preparata 80g, Fructus Corni (processed) 40g, Cortex Moutan 30g, Rhizoma Dioscoreae 40g, Poria 30g, Rhizoma Alismatis 30g
Technology: Radix Ophiopogonis powder is broken into 80 purpose fine powders, the Cortex Moutan pulverize at low temperature becomes 80 purpose fine powders; Fructus Corni, Fructus Schisandrae Chinensis, Rhizoma Alismatis are with 50% ethanol extraction 3 times, added for the first time 10 times of amount 50% ethanol extractions 5 hours, added for the second time 8 times of amount 50% ethanol extractions 3 hours, added 5 times of amount 50% ethanol extractions for the third time 1 hour, filter, merge extractive liquid, reclaims ethanol, and being condensed into when relative density is 80 ℃ is 1.10～1.15 thick pastes; Radix Rehmanniae Preparata is earlier with boiling water lixiviate 3 hours, decoct with water 4 times with Rhizoma Dioscoreae, Poria again, adding for the first time 10 times of water gagings extracted 3 hours, adding for the second time 8 times of water gagings extracted 2 hours, add 6 times of water gagings for the third time and extracted 1 hour, add 5 times of water gagings and extracted collecting decoction 0.5 hour for the 4th time, filter, it is 1.10～1.15 thick pastes that filtrate is condensed into when relative density is 80 ℃; Above-mentioned fine powder and thick paste mixing are made granule, and 60 ℃ of dryings add the magnesium stearate of dried grain amount 0.5% again, mixing, and tabletting, the bag film-coat promptly gets tablet.
Usage and consumption: oral, a 3-4 sheet, 3 times on the one.
Embodiment 4:
Prescription: Radix Ophiopogonis 120g, Fructus Schisandrae (processed) 20g, Radix Rehmanniae Preparata 80g, Fructus Corni (processed) 160g, Cortex Moutan 30g, Rhizoma Dioscoreae 40g, Poria 120g, Rhizoma Alismatis 120g
Technology: Radix Ophiopogonis powder is broken into 120 purpose fine powders, the Cortex Moutan pulverize at low temperature becomes 120 purpose fine powders; Fructus Corni, Fructus Schisandrae Chinensis, Rhizoma Alismatis added 10 times of amount 70% ethanol extractions for the first time 4 hours with 70% ethanol extraction 2 times, added 8 times of amount 70% ethanol extractions for the second time 2 hours, filter, merge extractive liquid, reclaims ethanol, and being condensed into when relative density is 80 ℃ is 1.10～1.15 thick pastes; Radix Rehmanniae Preparata is earlier with boiling water lixiviate 5 hours, decoct with water 3 times with Rhizoma Dioscoreae, Poria again, adding for the first time 10 times of water gagings extracted 2 hours, adding for the second time 8 times of water gagings extracted 2 hours, adding 5 times of water gagings for the third time extracted 0.5 hour, collecting decoction filters, and it is 1.10～1.15 thick pastes that filtrate is condensed into when relative density is 80 ℃; Above-mentioned fine powder and thick paste mixing are made granule, and 60 ℃ of dryings add the magnesium stearate of dried grain amount 1% again, mixing, and tabletting, sugar coating promptly gets tablet.
Usage and consumption: oral, a 3-4 sheet, 3 times on the one.
Claims (7)
1. the preparation method of a MAIWEI DIHUANG KOUFU ZHIJI, it is characterized in that: calculate according to composition by weight, it by Radix Ophiopogonis 30-120, Fructus Schisandrae (processed) 20-80, Radix Rehmanniae Preparata 80-320, Fructus Corni (processed) 40-160, Cortex Moutan 30-120, Rhizoma Dioscoreae 40-160, Poria 30-120, Rhizoma Alismatis 30-120 and adjuvant be prepared from according to following method: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, dry below 60 ℃ and 60 ℃, pulverize, add conventional adjuvant again and can make different oral formulations according to conventional method.
2. according to the preparation method of the described MAIWEI DIHUANG KOUFU ZHIJI of claim 1, it is characterized in that: concrete preparation method is: Radix Ophiopogonis powder is broken into 80 purpose fine powders, the Cortex Moutan pulverize at low temperature becomes 80 purpose fine powders; Fructus Corni, Fructus Schisandrae Chinensis, Rhizoma Alismatis add 8 times of amount 65% ethanol for the first time with 65% ethanol extraction 2 times, add 6 times of amount 65% ethanol for the second time, each 2 hours, filter merge extractive liquid,, reclaim ethanol, being condensed into when relative density is 80 ℃ is 1.10～1.15 thick pastes; Radix Rehmanniae Preparata with boiling water lixiviate 5 hours, decocts with water three times with Rhizoma Dioscoreae, Poria earlier again, and each 1 hour, add 10 times of water gagings for the first time, second and third time adds 8 times of water gagings, and collecting decoction filters, and it is 1.10～1.15 thick pastes that filtrate is condensed into when relative density is 80 ℃; Above-mentioned fine powder and thick paste mixing, 60 ℃ of dryings are pulverized, and add conventional adjuvant again and can make different oral formulations according to conventional method.
3. according to the preparation method of claim 1 or 2 described MAIWEI DIHUANG KOUFU ZHIJI, it is characterized in that: described oral formulations is meant capsule, tablet and pill.
4. according to the preparation method of the described MAIWEI DIHUANG KOUFU ZHIJI of claim 3, it is characterized in that: described tablet comprises coated tablet and Film coated tablets.
5. according to the preparation method of the described MAIWEI DIHUANG KOUFU ZHIJI of claim 3, it is characterized in that: the preparation method of described capsule is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, dry below 60 ℃ and 60 ℃, pulverize, add 0.5% magnesium stearate, mixing incapsulates, promptly.
6. according to the preparation method of the described MAIWEI DIHUANG KOUFU ZHIJI of claim 3, it is characterized in that: the preparation method of described pill is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing, pill, dry below 60 ℃ and 60 ℃, polishing or sugar coating or bag film-coat promptly get pill.
7. according to the preparation method of the described MAIWEI DIHUANG KOUFU ZHIJI of claim 4, it is characterized in that: the preparation method of described tablet is: Radix Ophiopogonis powder is broken into fine powder, the Cortex Moutan pulverize at low temperature becomes fine powder; Fructus Corni, Fructus Schisandrae Chinensis and Rhizoma Alismatis add 5-10 doubly measures, the ethanol extraction of 50-85% 1-3 time, and each 1-5 hour, filter, merge extractive liquid, reclaims ethanol and is condensed into thick paste; Radix Rehmanniae Preparata adds 5-10 times of water gaging with Rhizoma Dioscoreae, Poria again and decocts 1-4 time earlier with boiling water lixiviate 3-8 hour, and each 0.5-3 hour, collecting decoction filtered, and filtrate is condensed into thick paste; Above-mentioned fine powder and thick paste mixing are made granule, and be dry below 60 ℃ and 60 ℃, adds dried grain amount 0.5-1% magnesium stearate again, mixing, and tabletting, sugar coating or film-coat promptly get tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110171874XA CN102225152B (en) | 2011-06-23 | 2011-06-23 | Preparation method of Maiwei rehmannia oral preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110171874XA CN102225152B (en) | 2011-06-23 | 2011-06-23 | Preparation method of Maiwei rehmannia oral preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102225152A true CN102225152A (en) | 2011-10-26 |
| CN102225152B CN102225152B (en) | 2012-07-25 |
Family
ID=44806180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110171874XA Active CN102225152B (en) | 2011-06-23 | 2011-06-23 | Preparation method of Maiwei rehmannia oral preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102225152B (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104095233A (en) * | 2014-06-27 | 2014-10-15 | 桂林浩新科技服务有限公司 | Medicated diet for treating diabetes |
| CN104256502A (en) * | 2014-09-30 | 2015-01-07 | 中盐东兴盐化股份有限公司 | Method for preparing liver protecting and kidney tonifying bamboo salt |
| CN104352949A (en) * | 2014-10-11 | 2015-02-18 | 孙启玉 | Traditional Chinese medicine oral ointment for treating early-stage thyroid cancer as well as preparation method and preparation equipment thereof |
| CN104524359A (en) * | 2014-12-31 | 2015-04-22 | 吉林省德商药业有限公司 | Traditional Chinese medicine composition and preparing method and application thereof |
| CN104666856A (en) * | 2013-11-30 | 2015-06-03 | 白杨 | Method for preparing pepsase and trypsase processed wheat taste rehmannia micro-ecological oral solution |
| CN104666854A (en) * | 2013-11-30 | 2015-06-03 | 白杨 | Preparation method of pepsase and trypsase processed Maiwei rehmannia oral liquid |
| CN104666852A (en) * | 2013-11-30 | 2015-06-03 | 白杨 | Preparation method of maiwei (Chinese character) radix rehmanniae oral liquid treated by pepsase |
| CN104857271A (en) * | 2014-10-14 | 2015-08-26 | 磐安县道地磐药中药研究所 | Traditional Chinese medicine decoction piece combination preparation enhancing body immunity, preparation method therefor and combination package |
| CN105497499A (en) * | 2015-12-29 | 2016-04-20 | 贵州弘康药业有限公司 | Preparing method of Mai Wei Di Huang preparation |
| CN105560809A (en) * | 2015-12-29 | 2016-05-11 | 贵州弘康药业有限公司 | Production process of preparation containing radix ophiopogonis, processed schisandra chinensis and prepared rehmannia root |
| CN111407865A (en) * | 2020-04-13 | 2020-07-14 | 贺启飞 | Pulmonary perforation combined traditional Chinese medicine formula for treating pulmonary tuberculosis |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1775264A (en) * | 2005-11-18 | 2006-05-24 | 北京阜康仁生物制药科技有限公司 | Maiwei-dihuang preparation and new preparing method |
| CN100420471C (en) * | 2005-04-28 | 2008-09-24 | 贵州益佰制药股份有限公司 | Oral taking preparation of Chinese traditional medicine for nourishing the kidney and the lung |
| CN101700349A (en) * | 2008-11-24 | 2010-05-05 | 四川旭阳药业有限责任公司 | Liquid hard capsule of Anagex extract and preparation method thereof |
-
2011
- 2011-06-23 CN CN201110171874XA patent/CN102225152B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100420471C (en) * | 2005-04-28 | 2008-09-24 | 贵州益佰制药股份有限公司 | Oral taking preparation of Chinese traditional medicine for nourishing the kidney and the lung |
| CN1775264A (en) * | 2005-11-18 | 2006-05-24 | 北京阜康仁生物制药科技有限公司 | Maiwei-dihuang preparation and new preparing method |
| CN101700349A (en) * | 2008-11-24 | 2010-05-05 | 四川旭阳药业有限责任公司 | Liquid hard capsule of Anagex extract and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 《中国药师》 20080630 周义录等 麦味地黄口服液制备工艺考察 667-668 1-7 第11卷, 第6期 * |
| 《中国药理与临床》 19970131 熊永德等 麦味地黄颗粒剂对阴虚证模型动物的影响 6-8 1-7 第13卷, 第1期 * |
| 《中药成方制剂第五册》 19921231 中华人民共和国卫生部药典委员会 麦味地黄片 71 1-7 , * |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104666856A (en) * | 2013-11-30 | 2015-06-03 | 白杨 | Method for preparing pepsase and trypsase processed wheat taste rehmannia micro-ecological oral solution |
| CN104666854A (en) * | 2013-11-30 | 2015-06-03 | 白杨 | Preparation method of pepsase and trypsase processed Maiwei rehmannia oral liquid |
| CN104666852A (en) * | 2013-11-30 | 2015-06-03 | 白杨 | Preparation method of maiwei (Chinese character) radix rehmanniae oral liquid treated by pepsase |
| CN104095233A (en) * | 2014-06-27 | 2014-10-15 | 桂林浩新科技服务有限公司 | Medicated diet for treating diabetes |
| CN104256502A (en) * | 2014-09-30 | 2015-01-07 | 中盐东兴盐化股份有限公司 | Method for preparing liver protecting and kidney tonifying bamboo salt |
| CN104352949A (en) * | 2014-10-11 | 2015-02-18 | 孙启玉 | Traditional Chinese medicine oral ointment for treating early-stage thyroid cancer as well as preparation method and preparation equipment thereof |
| CN104857271B (en) * | 2014-10-14 | 2018-04-17 | 磐安县道地磐药中药研究所 | Strengthen immunity of organisms prepared slices of Chinese crude drugs combination preparation, preparation method and assembly packaging |
| CN104857271A (en) * | 2014-10-14 | 2015-08-26 | 磐安县道地磐药中药研究所 | Traditional Chinese medicine decoction piece combination preparation enhancing body immunity, preparation method therefor and combination package |
| CN104524359A (en) * | 2014-12-31 | 2015-04-22 | 吉林省德商药业有限公司 | Traditional Chinese medicine composition and preparing method and application thereof |
| CN104524359B (en) * | 2014-12-31 | 2017-08-25 | 吉林省德商药业有限公司 | A kind of Chinese medicine composition, its preparation method and application |
| CN105560809A (en) * | 2015-12-29 | 2016-05-11 | 贵州弘康药业有限公司 | Production process of preparation containing radix ophiopogonis, processed schisandra chinensis and prepared rehmannia root |
| CN105497499A (en) * | 2015-12-29 | 2016-04-20 | 贵州弘康药业有限公司 | Preparing method of Mai Wei Di Huang preparation |
| CN105497499B (en) * | 2015-12-29 | 2019-05-24 | 贵州弘康药业有限公司 | A kind of production method of Maiwei-dihuang preparation |
| CN111407865A (en) * | 2020-04-13 | 2020-07-14 | 贺启飞 | Pulmonary perforation combined traditional Chinese medicine formula for treating pulmonary tuberculosis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102225152B (en) | 2012-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102225152B (en) | Preparation method of Maiwei rehmannia oral preparation | |
| CN101991744B (en) | Traditional Chinese medicine perfusion agent for treating milk cow endometritis | |
| CN102813752B (en) | Preparation method of creeping dichondra-berchemia lineata-verbena Gantai preparation | |
| CN1951424A (en) | Pharmaceutical composition for treating gynecological inflammation and preparation method thereof | |
| CN103385830A (en) | Traditional Chinese medicine composition and its preparation method and use | |
| CN103301377A (en) | Natural pharmaceutical composition | |
| CN1883607B (en) | Pharmaceutical composition for treating gynecological inflammation and method for preparing same | |
| CN101214325B (en) | Method for preparing compound 'chenxiangwei'medicine and new use thereof | |
| CN101116680A (en) | Traditional Chinese medicine preparation for treating sphagitis | |
| CN1895361B (en) | Chinese-medicinal composition for treating gynecological inflammation and its preparation | |
| CN103356831A (en) | Natural pharmaceutical composition and preparation method thereof | |
| CN114073740B (en) | Preparation method of dripping pills for regulating qi and activating blood circulation | |
| CN101904906B (en) | Rhizoma corydalis pain-relieving dripping pill preparation and preparation process thereof | |
| CN101468060A (en) | Pharmaceutical composition | |
| CN1899428B (en) | Chinese medicine preparation for treating pain and its preparing method | |
| CN104116795B (en) | A kind of have Chinese medicine composition of anti-skin carcinoma activity and uses thereof | |
| CN104840746B (en) | A kind of Chinese medicine composition with anti-lung cancer activity and its preparation method and application | |
| CN103655806A (en) | Natural medicine composition as well as preparation method and application thereof | |
| CN103393812A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN103356754A (en) | Chinese medicinal composition | |
| CN103263541A (en) | Extract from traditional Chinese medicine and its preparation method | |
| CN102631486A (en) | Health care composition | |
| CN108079249A (en) | A kind of Chinese medicine preparation with liver protection and preparation method thereof | |
| CN108653686A (en) | A kind of Chinese medicine composition and preparation method thereof for treating oophoroma | |
| CN104069272A (en) | A traditional Chinese medicine composition having anticancer effects and a preparing method and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of Maiwei rehmannia oral preparation Effective date of registration: 20160115 Granted publication date: 20120725 Pledgee: Agricultural Bank Chinese Limited by Share Ltd Longli County branch Pledgor: Guizhou Hongkang Pharmaceutical Co., Ltd. Registration number: 2016520000001 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170801 Granted publication date: 20120725 Pledgee: Agricultural Bank Chinese Limited by Share Ltd Longli County branch Pledgor: Guizhou Hongkang Pharmaceutical Co., Ltd. Registration number: 2016520000001 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of Maiwei Dihuang oral preparation Effective date of registration: 20210809 Granted publication date: 20120725 Pledgee: Agricultural Bank Chinese Limited by Share Ltd. Longli County branch Pledgor: GUIZHOU HONGKANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2021520000010 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |